← All trials
NCT06449339
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Jul 17, 2024
- Primary completion
- Jul 30, 2031
- Completion date
- Jul 30, 2031
- First posted
- Jun 10, 2024
- Last posted
- Aug 27, 2024
- Enrollment
- 474
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Chinese University of Hong KongLead sponsor
- Chinese University of Hong KongOfficial
- University of BordeauxCollaborator
- Jiao Tong UniversityCollaborator
- University of MalayaCollaborator
- Chinese University of Hong KongSponsor investigator
- Singapore General HospitalCollaborator
- University of PalermoCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.